Gregory Lambert

This inventor holds 23 USPTO granted patents and 2 published patent applications, plus 11 CIPO patents and 2 EPO patents, primarily in Ophthalmic Emulsions. Top assignees: Santen Sas, Novagali Pharma Sa, National Institute of Health and Medical Research. Active years: 2003-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregory Lambert. Retrieved from https://idiyas.com/inventor/gregory-lambert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 2)

% Patents Active = 87.0

CIPO Patents = 11 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 76(Granted Patents)

Location History:

Verrieres le Buisson, FR (2003)
Malabry, FR (2012)
Châtenay-Malabry, FR (2020 - 2022)
Rouen, FR (2020 - 2022)
Chatenay Malabry, FR (2010 - 2023)

Company Filing History:

National Institute of Health and Medical Research

Centre Hospitalier Universitaire De Rouen

Sofic (Ste Francaise D'instruments De Chirurgie)

patents

9. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2023

Loading Chart...

Areas of Expertise:

Oil-in-Water Emulsions

Cetalkonium Chloride

Pharmaceutical Compositions

Satiation Induction

Metabolic Syndrome

Eye Disease Treatment

Quaternary Ammonium Compounds

Ophthalmic Applications

Topical Compositions

Bacterial Influence

Cationic Agents

Therapeutic Agents

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11612658 - Oil-in-water emulsions comprising cetalkonium chloride and methods of making and using the same (2023-03-28),

2. 11389489 - Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof (2022-07-19),

3. 11369645 - Hafnia alvei impact on regulation of appetite and metabolic syndrome aspects (2022-06-28),

4. 10888592 - based pharmaceutical and food compositions for inducing satiation and prolonging satiety (2021-01-12),

5. 10842873 - Methods for preparing oil-in-water emulsions comprising cetalkonium chloride (2020-11-24),

6. 10729770 - Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH (2020-08-04),

7. 10682389 - Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof (2020-06-16),

8. 9956289 - Emulsion compositions containing quaternary ammonium compounds (2018-05-01),

9. 9789262 - Sheath protecting a cannula, and safety syringe comprising said sheath (2017-10-17),

10. 9364461 - Process for manufacturing ophthalmic oil-in-water emulsions (2016-06-14),

11. 9220694 - Emulsion compositions containing cetalkonium chloride (2015-12-29),

12. 9192567 - Method for treating eye disease or conditions affecting the posterior segment of the eye (2015-11-24),

13. 9132071 - Compositions containing quaternary ammonium compounds (2015-09-15),

14. 8623852 - Topical methods and compositions for the treatment of eye diseases and conditions (2014-01-07),

15. 8524779 - Emulsion compositions containing quaternary ammonium compounds (2013-09-03),

Title: Gregory Lambert: Innovator in Pharmaceutical and Emulsion Technologies

Introduction

Gregory Lambert, based in Chatenay Malabry, France, is a prolific inventor with an impressive portfolio of 22 patents. His work primarily focuses on pharmaceutical formulations and oil-in-water emulsions, reflecting his commitment to innovation in the fields of healthcare and consumer products.

Latest Patents

Among Gregory Lambert's most recent inventions are two notable patents. The first relates to oil-in-water emulsions comprising cetalkonium chloride, detailing compositions that include quaternary compounds and significant quantities of ammonium halides. These emulsions have various applications, particularly in ophthalmology, providing solutions that aid in eye care and treat eye conditions.

The second patent addresses pharmaceutical and food compositions designed to induce satiation and prolong feelings of fullness in individuals requiring such interventions. This invention specifies methods involving the administration of ClpB protein or bacteria that express this protein to promote satiation.

Career Highlights

Throughout his career, Gregory Lambert has contributed significantly to various organizations, including Santen SAS and Novagali Pharma SA. His work has led to advancements in pharmaceutical technology and consumer health products, establishing him as an influential figure in his industry.

Collaborations

Gregory has collaborated with esteemed colleagues such as Betty Philips and Laura Rabinovich-Guilatt, enriching his projects with diverse expertise. These professional relationships have enhanced the innovation processes, fostering an environment conducive to breakthrough developments in their respective fields.

Conclusion

With a wealth of patents and collaborative efforts, Gregory Lambert stands out as an impactful inventor whose innovations continue to shape the landscape of pharmaceutical and emulsion technology. His dedication to advancing industry practices ensures that his work will have lasting benefits for both healthcare providers and patients alike.

Profile summary based on public USPTO records.